Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH Therapy for Distress in Idiopathic Short Stature
NCT01246219Phase 4Completed
- Sponsor
- Rabin Medical Center
- Start
- Oct 2011
- Primary completion
- Nov 2017
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of somatropin in Idiopathic Short Stature (ISS) (3 arms), sponsored by Rabin Medical Center. Primary endpoint: Psychological Distress score at 4 years. Started Oct 2011; status: completed.
02
Drugs
somatropin
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on NCT01246219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01246219.